SALIRI Based Regimen as First-line Treatment for Advanced Metastatic Colorectal Cancer

ABSTRACT: The objective is to investigate the efficacy and safety of raltitrexed combined with Irinotecan (SALIRI) based regimen as first-line treatment for advanced metastatic colorectal cancer(mCRC).

DISEASE(S): Advanced Metastatic Colorectal Cancer,Colorectal Neoplasms

PROVIDER: 2398610 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR